Full Text View
Tabular View
No Study Results Posted
Related Studies
Adjuvant Adenovirus-Thymidine Kinase Enzyme (ADV-TK) Gene Therapy Improves Survival in Patients With Gliomas
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Huazhong University of Science and Technology.
Recruitment status was  Recruiting
Study NCT00870181   Information provided by Huazhong University of Science and Technology

First Received on March 26, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Interventions listed in this trial
ADV-TK
Sponsors listed in this trial
Huazhong University of Science and Technology
Capital Medical University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services